Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-24-000052
Filing Date
2024-01-02
Accepted
2024-01-02 08:00:17
Documents
2
Period of Report
2023-12-29

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea190894-6k_alterity.htm 6-K 13747
2 OPTIONS PROSPECTUS ea190894ex99-1_alterity.htm EX-99.1 251409
  Complete submission text file 0001213900-24-000052.txt   266301
Mailing Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000
Business Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000 61 3 9349 4906
ALTERITY THERAPEUTICS LTD (Filer) CIK: 0001131343 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-49843 | Film No.: 24500279
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)